Chen S, Wang J, Siegelbaum SA (2001) Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1
and HCN2 subunits and basal modulation by cyclic nucleotide.
J Gen Physiol 117:491–504.
Chien PE, Farkas RH, Nakajima S, Nakajima Y (1996) Single-channel
properties of the non-selective cation conductance induced by
neurotensin in dopaminergic neurones. Proc Natl Acad Sci U S A
93:14917–14921.
Cooper DC (2002) The significance of the action potential bursting in
the brain reward circuit. Neurochem Int 41:333–340.
Dardonville C, Rozas I (2004) Imidazoline binding sites and their
ligands: an overview of the different chemical structures. Med Res
Rev 24:639 – 661.
Docherty JR (1998) Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur J Pharmacol 361:1–15.
Dorn GW II, Oswald KJ, McCluskey TS, Kuhel DG, Liggett SB (1997)
Alpha 2A-adrenergic receptor stimulated calcium release is transduced by Gi-associated G(beta gamma)-mediated activation of
phospholipase C. Biochemistry 36:6415– 6423.
Ernsberger P, Friedman JE, Koletsky RJ (1997) The I1-imidazoline
receptor: from binding site to therapeutic target in cardiovascular
disease. J Hypertens Suppl 15:S9 –S23.
Ernsberger P, Damon TH, Graff LM, Schafer SG, Christen MO (1993)
Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. J Pharmacol Exp Ther 264:
172–182.
Farkas RH, Chien PY, Nakajima S, Nakajima Y (1996) Properties of a
slow nonselective cation conductance modulated by neurotensin
and others neurotransmitters in midbrain dopaminergic neurons.
J Neurophysiol 76:1968 –1981.
Ferry D, Armah BI, Goll A, Glossmann H (1988) Characteristics of the
binding of antihypertensive agent moxonidine to 2-adrenoceptors
in rat brain membranes. Arzneimittelforschung 38:1442–1445.
Grace AA, Floresco SB, Goto Y, Lodge DJ (2007) Regulation of firing
of dopaminergic neurons and control of goal-directed behaviors.
Trends Neurosci 30:220 –227.
Grace AA (2000) The tonic/phasic model of dopamine system regulation and its implication for understanding alcohol and psychostimulant craving. Addiction 95(Suppl 2):S119 –S128.
Grace AA (1991) Phasic versus tonic dopamine release and the
modulation of dopamine system responsivity: a hypothesis for the
etiology of schizophrenia. Neuroscience 41:1–24.
Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and
characterization. Neuroscience 10:301–315.
Harrison JK, D'Angelo DD, Zeng DW, Lynch KR (1991) Pharmacological characterization of rat alpha 2-adrenergic receptors. Mol Pharmacol 40:407– 412.
Herbert JM, Augereau JM, Gleye J, Maffrand JP (1990) Chelerythrine
is a potent and specific inhibitor of protein kinase C. Biochem
Biophys Res Commun 172:993–999.
Hofmann F, Biel M, Kaupp UB (2003) International Union of Pharmacology. XLII. Compendium of voltage-gated ion channels: cyclic
nucleotide-modulated channels. Pharmacol Rev 55:587–589.
Hopf FW, Martin M, Chen BT, Bowers MS, Mohamedi MM, Bonci A
(2007) Withdrawal from intermittent ethanol exposure increases
probability of burst firing in VTA neurons in vitro. J Neurophysiol
98:2297–2310.
Hudson A (2000) Imidazoline receptors. In: Tocris reviews, pp. 1– 4.
Jansson CC, Kukkonen JP, Nasman J, Huifang G, Wurster S, Virtanen
R, Savola JM, Cockcroft V, Akerman KE (1998) Protean agonism
at alpha2A-adrenoceptors. Mol Pharmacol 53:963–968.
Jansson CC, Marjamaki A, Luomala K, Savola JM, Scheinin M, Akerman KE (1994) Coupling of human alpha 2-adrenoceptor subtypes
to regulation of cAMP production in transfected S115 cells. Eur
J Pharmacol 266:165–174.
